Technology·Diagnosis
OICR-supported researchers and collaborators discover indicators in the blood that may predict which patients will respond to the immunotherapy drug, pembrolizumab Adapted from UHN’s Media Release. Immunotherapy can shrink tumours and prolong survival for certain…
Article·